| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Canaccord Genuity reiterates Buy rating on Alarum Technologies stock | ||
| Fr | Truist Securities raises Deere stock price target to $612 on bullish outlook | ||
| Fr | Guggenheim maintains Buy rating on Dollar General stock ahead of earnings | ||
| Fr | Telsey raises Macy's stock price target to $22 on strategic repositioning | ||
| Fr | JPMorgan discloses securities dealings in Avadel Pharmaceuticals | ||
| Fr | Dragonfly Energy launches portable power station line for industrial use | ||
| Fr | Western Gas Partners price target raised to $42 from $39 at RBC Capital | ||
| Fr | Deere price target lowered to $541 from $542 at RBC Capital | ||
| Fr | PMGR Securities 2025 announces liquidation, final ZDP share payout | ||
| Fr | Electra Battery Materials stock holds Buy rating at H.C. Wainwright on supply deal | ||
| Fr | H.C. Wainwright reiterates Buy rating on BiomX stock amid FDA queries | ||
| Fr | Structure Therapeutics stock holds Buy rating at H.C. Wainwright ahead of key trials | ||
| Fr | Vera Therapeutics stock steady as H.C. Wainwright reiterates Buy rating | ||
| Fr | Halozyme stock rating reiterated at Buy by H.C. Wainwright after Elektrofi acquisition | ||
| Fr | Mizuho maintains Outperform rating on Terns Pharmaceuticals stock ahead of ASH data | ||
| Fr | Anavex stock holds Buy rating at H.C. Wainwright amid Alzheimer's unmet need | ||
| Fr | H.C. Wainwright reaffirms Buy rating on Microbot Medical stock at $12 | ||
| Fr | Mizuho raises Arcutis Biotherapeutics stock price target on strong Zoryve sales | ||
| Fr | Centrica completes acquisition of Grain LNG terminal | ||
| Fr | Whitbread expects £40-50m hit from UK budget business rates hike | ||
| Fr | Standard Bank Group reports solid capital and liquidity ratios in Q3 2025 | ||
| Fr | Sun Peak Metals closes oversubscribed private placement for $6.67 million | ||
| Fr | AbbVie's Skyrizi receives positive reimbursement recommendation for UC | ||
| Fr | Aurora Mobile partners with Fenbeitong for push notification services | ||
| Fr | FDA extends review deadline for Vanda's tradipitant clinical hold |